Molecular targets for treatment of inflammatory breast cancer.
about
Obesity and cancer, a case for insulin signalingInflammatory breast cancer: what we know and what we need to learnInteraction of low molecular weight hyaluronan with CD44 and toll-like receptors promotes the actin filament-associated protein 110-actin binding and MyD88-NFκB signaling leading to proinflammatory cytokine/chemokine production and breast tumor invaTargeting GLI1 expression in human inflammatory breast cancer cells enhances apoptosis and attenuates migration.AZD8931, an equipotent, reversible inhibitor of signaling by epidermal growth factor receptor (EGFR), HER2, and HER3: preclinical activity in HER2 non-amplified inflammatory breast cancer modelsAldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer.Protein interaction network underpins concordant prognosis among heterogeneous breast cancer signaturesDifferent gene expressions are associated with the different molecular subtypes of inflammatory breast cancerATX-LPA receptor axis in inflammation and cancer.Circulating tumor cells in newly diagnosed inflammatory breast cancer.Anaplastic lymphoma kinase gene copy number gain in inflammatory breast cancer (IBC): prevalence, clinicopathologic features and prognostic implication.Ganoderma lucidum (Reishi) inhibits cancer cell growth and expression of key molecules in inflammatory breast cancerInflammatory Breast Cancer: A Distinct Clinicopathological Entity Transcending Histological DistinctionInterferon-induced transmembrane protein 1 (IFITM1) overexpression enhances the aggressive phenotype of SUM149 inflammatory breast cancer cells in a signal transducer and activator of transcription 2 (STAT2)-dependent manner.Hyperactivated mTOR and JAK2/STAT3 Pathways: Molecular Drivers and Potential Therapeutic Targets of Inflammatory and Invasive Ductal Breast Cancers After Neoadjuvant ChemotherapyThe erbB3- and IGF-1 receptor-initiated signaling pathways exhibit distinct effects on lapatinib sensitivity against trastuzumab-resistant breast cancer cellsEZH2 knockdown suppresses the growth and invasion of human inflammatory breast cancer cells.Bevacizumab in HER2-negative inflammatory breast cancer.IBC as a Rapidly Spreading Systemic Disease: Clinical and Targeted Approaches Using the Neoadjuvant Model.Vascular endothelial growth factor (VEGF), mast cells and inflammation.miRNA expression profiling of inflammatory breast cancer identifies a 5-miRNA signature predictive of breast tumor aggressiveness.CSF-1/CSF-1R axis is associated with epithelial/mesenchymal hybrid phenotype in epithelial-like inflammatory breast cancer.
P2860
Q26771452-B146D113-CAF9-4D3E-AAF8-3BC8B57413F6Q27028128-C7576B8C-9639-49BA-BBE8-93CE74D51017Q28394879-53B6DC2B-3FC8-4BC5-AEBF-E6A91CF14BE2Q30500481-BA27CE20-AAF1-44B9-83B1-845F1BD0EEA9Q33770856-6B24AA29-1260-4EA3-9AF4-D3C697CFB459Q33870504-1E46A379-F50C-46E9-809B-7D00B919D0F7Q33886387-22AC80B5-A368-4C05-A024-C7F11491AF2CQ33942512-80A9F3DB-8DA2-4F38-ABF5-3940F6D0981FQ34199719-F3062194-5678-4487-81FD-0A94F3B4C092Q35052773-AA19542F-F732-49A9-999A-384FEBFA02E6Q35214370-E61FDCA1-DA8F-45FF-A848-91C1220FDCBBQ35448482-11CB26B5-68A5-404A-BDC2-8BEF3843C0E9Q35890623-75E42800-9DA0-4D4F-A4EF-5F0249C9592EQ36599823-8A57AFFE-0123-4DB6-BE23-DAE0277469A9Q36693275-22F6E560-08BF-426F-BA97-8F369FBDBD81Q36771985-ABFBC95B-1765-47E6-9D23-99E9BF1E6920Q37362586-B5955B05-4FF7-48F0-8664-47E5419F0EDEQ42330451-83CDC5EE-6E6C-43F5-8B85-2C1978F988A5Q42478176-29C742B6-0EAB-45FB-BD1B-2F0AADC000EAQ44817598-7521ED2B-EFEC-4DE3-B668-EBAFDA1BD883Q48111857-40D41DC8-C242-45ED-9518-F5F8B82862FDQ55322297-10DD2431-E424-427D-87A2-E029A9F6E3BC
P2860
Molecular targets for treatment of inflammatory breast cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular targets for treatment of inflammatory breast cancer.
@en
Molecular targets for treatment of inflammatory breast cancer.
@nl
type
label
Molecular targets for treatment of inflammatory breast cancer.
@en
Molecular targets for treatment of inflammatory breast cancer.
@nl
prefLabel
Molecular targets for treatment of inflammatory breast cancer.
@en
Molecular targets for treatment of inflammatory breast cancer.
@nl
P2093
P1476
Molecular targets for treatment of inflammatory breast cancer.
@en
P2093
Gabriel N Hortobagyi
Hideko Yamauchi
Massimo Cristofanilli
Naoto T Ueno
Seigo Nakamura
P2860
P2888
P304
P356
10.1038/NRCLINONC.2009.73
P407
P577
2009-05-26T00:00:00Z
P5875
P6179
1022695212